Peptide record

TPDB14998

Anti-inflammatory Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
77 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB14998
Anti-inflammatory Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides Immunity and inflammation peptides
Peptipedia dbAMP AFP-GFuse Antifp Antifungipept CAFPdb
standard
No
A 77-aa standard-residue multi-activity (Anti-inflammatory, Antibacterial, Anticancer, and other sources) peptide sequence curated from Peptipedia, dbAMP, AFP-GFuse, and other sources, with an available 3D structural model.
Sequence
SKCKCSRKGPKIRYSDVKKLEMKPKYPHCEEKMVIITTKSVSRYRGQEHCLHPKLQSTKRFIKWYNAWNEKRRVYEE
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C418H672N124O112S6
K
9419.06
10.27
24
8
22
+13
3.04
-1.240
51.82
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
18700
1.99
22
Residue Composition
number
1
A
7
R
2
N
1
D
4
C
7
E
2
Q
2
G
3
H
4
I
3
L
14
K
2
M
1
F
4
P
6
S
3
T
2
W
5
Y
4
V
Amino Acid Distribution
A: 1 R: 7 N: 2 D: 1 C: 4 E: 7 Q: 2 G: 2 H: 3 I: 4 L: 3 K: 14 M: 2 F: 1 P: 4 S: 6 T: 3 W: 2 Y: 5 V: 4
Chemical Descriptors
77 reviewed residue count
C418H672N124O112S6 sequence-only estimate (linear, free termini)
9419.06 sequence-only estimate (linear, free termini)
10.27 sequence-only estimate (linear, free termini)
+13 sequence-only estimate (linear, free termini)
3.04 sequence-only estimate (linear, free termini)
-1.240 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.32 µM

Target

Escherichia coli

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM
Evidence 2 Activity

Activity

MIC
Antibacterial
1.02 µM

Target

g. spp

Source & Reference

dbAMP

Other

Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM).
Evidence 3 Activity

Activity

MIC
Antibacterial
0.56 µM

Target

Candida albicans

Source & Reference

dbAMP

Other

ag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM). Activity is salt-sensitive, despite less than CCL20 or HBD2. In addition, Dai et al. fou
Evidence 4 Activity

Activity

MIC
Antifungal
0.32 µM

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM
Evidence 5 Activity

Activity

MIC
Antifungal
1.02 µM

Target

g. spp

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM).
Evidence 6 Activity

Activity

MIC
Antifungal
0.56 µM

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM). Activity is salt-sensitive, despite less than CCL20 or HBD2. In addition, Dai et al. fou
Evidence 7 Activity

Activity

MIC
Antiparasitic
0.32 µM

Target

Escherichia coli

Source & Reference

NA

Other

Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM
Evidence 8 Activity

Activity

MIC
Antiparasitic
1.02 µM

Target

g. spp

Source & Reference

NA

Other

Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM).
Evidence 9 Activity

Activity

MIC
Antiparasitic
0.56 µM

Target

Candida albicans

Source & Reference

NA

Other

ag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM). Activity is salt-sensitive, despite less than CCL20 or HBD2. In addition, Dai et al. fou
Evidence 10 Activity

Activity

MIC
Antiviral
0.32 µM

Target

Escherichia coli

Source & Reference

NA

Other

Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM
Evidence 11 Activity

Activity

MIC
Antiviral
1.02 µM

Target

g. spp

Source & Reference

NA

Other

Active against E. coli (MIC 0.32 uM), S. coag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM).
Evidence 12 Activity

Activity

MIC
Antiviral
0.56 µM

Target

Candida albicans

Source & Reference

NA

Other

ag. neg. spp (MIC 1.02 uM), Propionibacterium spp (MIC 1.16 uM), S. aureus (5.17 uM), and C. albicans (MIC 0.56 uM). Activity is salt-sensitive, despite less than CCL20 or HBD2. In addition, Dai et al. fou